UnitedHealth Group Loss on Sale of Subsidiary decreased by 102.4% to -$83.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 315.0%, from -$20.00M to -$83.00M. This is a positive signal — lower values indicate better performance for this metric.
An increase in losses on sales may indicate poor historical capital allocation or a strategic exit from underperforming business lines.
This represents the non-cash accounting loss recognized when a company disposes of a subsidiary or business unit for les...
Specific to companies undergoing restructuring or portfolio optimization; comparable to 'loss on disposal of assets'.
cf_unh_loss_on_sale_of_subsidiary| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$7.09B | -$1.23B | -$20.00M | $0.00 | -$15.00M | -$41.00M | -$83.00M |
| QoQ Change | — | — | — | — | — | — | — | — | — | +82.7% | +98.4% | +100.0% | — | -173.3% | -102.4% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | +99.8% | +96.7% | -315.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.